Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

FibroGen Inc. (FGEN)

43.5   1.37 (3.25%) 07-02 16:00
Open: 42.89 Pre. Close: 42.13
High: 43.99 Low: 42.31
Volume: 520,516 Market Cap: 3,876M
FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 44.047 - 44.225 44.225 - 44.395
Low: 41.874 - 42.069 42.069 - 42.254
Close: 43.185 - 43.494 43.494 - 43.787

Technical analysis

as of: 2020-07-02 4:30:04 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 51.38     One year: 60.01
Support: Support1: 36.65    Support2: 32.12
Resistance: Resistance1: 43.99    Resistance2: 51.38
Pivot: 40.98
Moving Average: MA(5): 41.43     MA(20): 39.45
MA(100): 37.25     MA(250): 40.38
MACD: MACD(12,26): 1.60     Signal(9): 1.38
Stochastic oscillator: %K(14,3): 79.55     %D(3): 72.99
RSI: RSI(14): 64.36
52-week: High: 48.95  Low: 22.65  Change(%): 1.8
Average Vol(K): 3-Month: 70635  10-Days: 76287

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
FGEN has closed below upper band by 6.5%. Bollinger Bands are 40.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to FGEN's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 02 Jul 2020
FibroGen Inc (FGEN) Soars 3.25% on July 02 -

Wed, 01 Jul 2020
Market Reactions to FibroGen Inc (FGEN) Stock Getting a Bearish Rating - InvestorsObserver

Fri, 26 Jun 2020
FibroGen, Inc. (FGEN) market price of $42.83 offers the impression of an exciting value play - The InvestChronicle

Thu, 25 Jun 2020
FibroGen Inc (FGEN) Soars 2.12% on June 25 -

Wed, 24 Jun 2020
Do Traders View FibroGen Inc (FGEN) Stock's Current Trend Positively? - InvestorsObserver

Mon, 22 Jun 2020
Is FibroGen Inc (FGEN) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 89
Shares Float (M) 83
% Held by Insiders 8.27
% Held by Institutions 74.70
Shares Short (K) 6,580
Shares Short P. Month (K) 6,690

Stock Financials

EPS -1.260
EPS Est This Year -1.810
EPS Est Next Year -0.950
Book Value (p.s.) 5.160
Profit Margin -42.75
Operating Margin -47.27
Return on Assets (ttm) -9.3
Return on Equity (ttm) -22.3
Qtrly Rev. Growth 2.3
Gross Profit (p.s.) 0.518
Sales Per Share 2.886
EBITDA (p.s.) -1.122
Qtrly Earnings Growth
Operating Cash Flow (M) -161
Levered Free Cash Flow (M) -211

Stock Valuations

PE Ratio -34.52
PEG Ratio
Price to Book value 8.43
Price to Sales 15.07
Price to Cash Flow -24.12

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.